| INSURANCE-COMPANIES |
INSURANCE-COMPANIES |
92%
|
We derive a substantial portion of our revenues from a limited number of clients, insurance companies, in our marketing promotion services business. |
| XYF |
X Financial |
72%
|
ding performance of our ADSs, regardless of our actual operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, c… |
| XYF |
X Financial |
72%
|
Reciprocal relationship from XYF graph: Reciprocal relationship from AHG graph: Reciprocal relationship from XYF graph: Reciprocal relationship from AHG graph: Reciprocal relationship from XYF graph:… |
| ACCORDINGLY-HEXINDAI-HONG-KONG-LIMITED |
ACCORDINGLY-HEXINDAI-HONG-KONG-LIMITED |
62%
|
t control over economic growth in the PRC. Because of the nature of our business, we are dependent upon the PRC government pursuing policies that encourage private ownership of businesses. Restrictio… |
| BEIJING-HEXIN-YONGHENG-TECHNOLOGY-DEVELOPMENT-CO |
BEIJING-HEXIN-YONGHENG-TECHNOLOGY-DEVELOPMENT-CO |
62%
|
s accounted for 36.3 %, 34.8 % and 28.0 % for the Company’s total revenue from sales of medical devices business. For the year ended March 31, 2023, three customers accounted for 59.5 %, 11.1 % and 1… |
| COMPANY-HEXIN-E-COMMERCE-COMPANY-LIMITED |
COMPANY-HEXIN-E-COMMERCE-COMPANY-LIMITED |
62%
|
s accounted for 36.3 %, 34.8 % and 28.0 % for the Company’s total revenue from sales of medical devices business. For the year ended March 31, 2023, three customers accounted for 59.5 %, 11.1 % and 1… |
| COMPANY-KUAISHANGCHE-AUTOMOBILE-LEASING-CO-LTD |
COMPANY-KUAISHANGCHE-AUTOMOBILE-LEASING-CO-LTD |
62%
|
s accounted for 36.3 %, 34.8 % and 28.0 % for the Company’s total revenue from sales of medical devices business. For the year ended March 31, 2023, three customers accounted for 59.5 %, 11.1 % and 1… |
| CONSOLIDATED-AFFILIATED-ENTITIES-AKSO-HEALTH-GRO |
CONSOLIDATED-AFFILIATED-ENTITIES-AKSO-HEALTH-GRO |
62%
|
hat reflect our current expectations and views of future events. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can ide… |
| DEYIHUI-GROUP |
DEYIHUI-GROUP |
62%
|
small commission for every purchase, share or recommendation of a product made to friends. In May 2023, to fully utilize the Company’s existing funds and resources and maximize the shareholders’ inte… |
| HEXIN-E-COMMERCE-CO-LTD |
HEXIN-E-COMMERCE-CO-LTD |
62%
|
ding performance of our ADSs, regardless of our actual operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, c… |
| HEXIN-YONGHENG-WUSU-COMPANY |
HEXIN-YONGHENG-WUSU-COMPANY |
62%
|
ding performance of our ADSs, regardless of our actual operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, c… |
| HX-ASIA-INVESTMENT-LIMITED |
HX-ASIA-INVESTMENT-LIMITED |
62%
|
s accounted for 36.3 %, 34.8 % and 28.0 % for the Company’s total revenue from sales of medical devices business. For the year ended March 31, 2023, three customers accounted for 59.5 %, 11.1 % and 1… |
| NAZHI-HENGSHENG-MEDICAL-EQUIPMENT-CO |
NAZHI-HENGSHENG-MEDICAL-EQUIPMENT-CO |
62%
|
urchase agreement. None of our subsidiaries have long-term agreements that obligate their supplier to continue supplying it with medical devices over the long term. Relationships with suppliers are s… |
| NAZHI-HENGSHENG-MEDICAL-EQUIPMENT-CO-LTD |
NAZHI-HENGSHENG-MEDICAL-EQUIPMENT-CO-LTD |
62%
|
urchase agreement. None of our subsidiaries have long-term agreements that obligate their supplier to continue supplying it with medical devices over the long term. Relationships with suppliers are s… |
| OVERSEAS-PUBLICLY-LISTED-COMPANY |
OVERSEAS-PUBLICLY-LISTED-COMPANY |
62%
|
t control over economic growth in the PRC. Because of the nature of our business, we are dependent upon the PRC government pursuing policies that encourage private ownership of businesses. Restrictio… |
| QINDAO-AKSO-HEALTH-MANAGEMENT-CO-LIMITED |
QINDAO-AKSO-HEALTH-MANAGEMENT-CO-LIMITED |
62%
|
hat reflect our current expectations and views of future events. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can ide… |
| QINGDAO-AKSO-HEALTH-MANAGEMENT-CO-LTD |
QINGDAO-AKSO-HEALTH-MANAGEMENT-CO-LTD |
62%
|
ilure to functions by our management, employees and parties that we collaborate with, who may from time to time be subject to litigation and regulatory investigations and proceedings or otherwise fac… |
| QINGDAO-YONGBAOYUN-TECHNOLOGY-CO-LTD |
QINGDAO-YONGBAOYUN-TECHNOLOGY-CO-LTD |
62%
|
urchase agreement. None of our subsidiaries have long-term agreements that obligate their supplier to continue supplying it with medical devices over the long term. Relationships with suppliers are s… |
| SICHUAN-NAZHI-TONGCHUANG-MEDICAL-EQUIPMENT-CO-LT |
SICHUAN-NAZHI-TONGCHUANG-MEDICAL-EQUIPMENT-CO-LT |
62%
|
urchase agreement. None of our subsidiaries have long-term agreements that obligate their supplier to continue supplying it with medical devices over the long term. Relationships with suppliers are s… |
| TIANJIN-AKSO-ENTERPRISE-MANAGEMENT-CO-LTD |
TIANJIN-AKSO-ENTERPRISE-MANAGEMENT-CO-LTD |
62%
|
rigination services, and other related services (the “ P2P Business ”). On December 30, 2020, we completed the disposal of the P2P Business and transitioned into a social e-commerce platform operator… |
| TIANJIN-DEYIHUI-CLINIC-CO-LIMITED |
TIANJIN-DEYIHUI-CLINIC-CO-LIMITED |
62%
|
small commission for every purchase, share or recommendation of a product made to friends. In May 2023, to fully utilize the Company’s existing funds and resources and maximize the shareholders’ inte… |
| TIAN-JIN-DEYIHUI-CLINIC-CO-LTD |
TIAN-JIN-DEYIHUI-CLINIC-CO-LTD |
62%
|
cal devices are subject to pre-approval licensing administration and will a receive medical device operation license upon the authorities’ approval (the “Class III Medical Device Operation License”).… |
| TIANJIN-DEYIHUI-ONLINE-HOSPITAL-CO-LIMITED |
TIANJIN-DEYIHUI-ONLINE-HOSPITAL-CO-LIMITED |
62%
|
small commission for every purchase, share or recommendation of a product made to friends. In May 2023, to fully utilize the Company’s existing funds and resources and maximize the shareholders’ inte… |
| TIAN-JIN-DEYIHUI-ONLINE-HOSPITAL-CO-LTD |
TIAN-JIN-DEYIHUI-ONLINE-HOSPITAL-CO-LTD |
62%
|
cal devices are subject to pre-approval licensing administration and will a receive medical device operation license upon the authorities’ approval (the “Class III Medical Device Operation License”).… |
| TIANJIN-HAOHONGYUAN-TECHNOLOGY-CO-LTD |
TIANJIN-HAOHONGYUAN-TECHNOLOGY-CO-LTD |
62%
|
hat reflect our current expectations and views of future events. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can ide… |
| TIANJIN-WANGYI-CLOUD-CO-LTD |
TIANJIN-WANGYI-CLOUD-CO-LTD |
62%
|
and synergies of combination for online and offline medical resources , the Company acquiring the remaining 50% equity interest of Tianjin Wangyi Cloud and its two wholly owned subsidiaries from the … |
| TIANJIN-WANGYI-CLOUD-CO-LTD-TIANJIN-WANGYI-CLOUD |
TIANJIN-WANGYI-CLOUD-CO-LTD-TIANJIN-WANGYI-CLOUD |
62%
|
rigination services, and other related services (the “ P2P Business ”). On December 30, 2020, we completed the disposal of the P2P Business and transitioned into a social e-commerce platform operator… |
| TRADING-CO-LTD |
TRADING-CO-LTD |
62%
|
s accounted for 36.3 %, 34.8 % and 28.0 % for the Company’s total revenue from sales of medical devices business. For the year ended March 31, 2023, three customers accounted for 59.5 %, 11.1 % and 1… |
| WFOE-BEIJING-HEXIN-YONGHENG-TECHNOLOGY-DEVELOPME |
WFOE-BEIJING-HEXIN-YONGHENG-TECHNOLOGY-DEVELOPME |
62%
|
hat reflect our current expectations and views of future events. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can ide… |
| WORKING-GROUP |
WORKING-GROUP |
62%
|
versely affect our business and results of operations and our business objectives may not be achieved at the pace we expected, or at all. We compete for skilled and quality employees, and failure to … |
